PeopleBio, Inc. (KOSDAQ:304840)
South Korea · Delayed Price · Currency is KRW 1,008.00
+8.00 (0.80%)
At close: Jun 12, 2026
PeopleBio Revenue
PeopleBio had revenue of 643.27M KRW in the quarter ending March 31, 2026, with 3.35% growth. This brings the company's revenue in the last twelve months to 2.87B, up 19.21% year-over-year. In the year 2025, PeopleBio had annual revenue of 2.85B with 12.64% growth.
Revenue (ttm)
2.87B
Revenue Growth
+19.21%
P/S Ratio
8.52
Revenue / Employee
n/a
Employees
n/a
Market Cap
24.46B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.85B | 319.91M | 12.64% |
| Dec 31, 2024 | 2.53B | -1.92B | -43.17% |
| Dec 31, 2023 | 4.45B | 8.02M | 0.18% |
| Dec 31, 2022 | 4.44B | 3.87B | 670.22% |
| Dec 31, 2021 | 577.08M | 69.23M | 13.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| GC Medical Science | 105.48B |
| Seoulin Bioscience | 78.58B |
| Cytogen | 26.84B |
| Protia | 16.25B |
| HLB Panagene | 14.64B |
| 3billion | 11.71B |
| GENINUS | 10.24B |
| Median Diagnostics | 7.86B |